Hakan CEYRAN, Murat BAŞARAN, Nihat ÇİNE, Eylem TUNÇER, Behzat TÜZÜN

Coronary revascularization in a 13 year old patient with homozygous familial hypercholesterolemia

Ailesel homozigot hiperkolesterolemi düşük yoğunluklu lipoprotein reseptör gen mutasyonlarından kaynaklanan otozomal dominant bir hastalıktır. Hastalık erken yaşta koroner arter hastalığı gelişme riskinde artış ile ilişkilidir. Bu yazıda, yaygın koroner arter hastalığı ve ailesel homo- zigot hiperkolesterolemisi olan ve başarılı koroner arter baypas greft cerrahisi yapılan 13 yaşında bir erkek olgu sunuldu

On üç yaşında bir homozigot ailevi hiperkolesterolemi hastasında koroner revaskülarizasyon

Homozygous familial hypercholesterolemia is an autosomal dominant disorder caused by mutations in the low density lipoprotein receptor gene. The disease is associated with an increased risk of coronary artery disease early in life. In this article, we present a 13-year-old boy with familial homozygous hypercholesterolemia who had an extensive coronary artery disease and underwent successful coronary artery bypass graft surgery

PDF

___

1. Ersoy U, Güvener M. Coronary revascularization in seven-yearold boy with homozygous familial hypercholesterolaemia. Acta Paediatr 2000;89:1501-2.
2. Nemati MH. Coronary revascularization in a child with homozygous familial hypercholesterolemia. Interact Cardiovasc Thorac Surg 2010;10:131-2.
3. Takahashi T, Nakano S, Kaneko M, Matsuda H, Taniguchi K, Nakamura T, et al. Coronary bypass using arterial grafts in homozygous familial hypercholesterolemia. Ann Thorac Surg 1992;53:510-2.
4. Bhan A, Swain S, Juneja R, Saxena P, Venugopal P. Total arterial revascularization in a child with familial homozygous hypercholesterolemia. J Thorac Cardiovasc Surg 2005;129:932-4.
5. El-Khouri HM, Danilowicz DA, Slovis AJ, Colvin SB, Artman M. Saphenous vein graft growth 13 years after coronary bypass in a child with Kawasaki disease. Ann Thorac Surg 1998;65:1127-30.
6. Tsuchida M, Kawashiri MA, Tada H, Takata M, Nohara A, Ino H, et al. Marked aortic valve stenosis progression after receiving long-term aggressive cholesterol-lowering therapy using low-density lipoprotein apheresis in a patient with familial hypercholesterolemia. Circ J 2009;73:963-6.